A company known as Bloomlife, which denotes itself as a women’s health technology company, has recently received two grants totaling around $2 million to help funding of fetal development wearable technology.
The CEO, Eric Dy, stated that ““These grants allow us to further develop and validate our prenatal wearable platform for labor detection (preterm and term) and remote fetal monitoring, the two areas of greatest concern especially for high risk moms. Building on these results, we will work closely with healthcare systems to integrate our solutions into clinical workflow.”
The monitoring system would effectively work for pregnant women to help keep track of their uterine activity. The user would place an adhesive strip on their stomach which would connect to an app on their smartphone, allowing them to access data within their body that is crucial to their health. The grant that comes from the European Commission Horizon program will help to fund different studies to help the algorithm that the company uses behind its products.
The grants will help the development of fetal heart rate and movement sensors as well, something that before, could only be done within the confines of a doctors office. The company Bloomlife, founded in 2014 out of San Francisco is working hard to produce this new technology. “Fetal movement and fetal heart rate are the two indicators of fetal health today,” Dr. Wilfried Gyselaers, principal investigator at Ziekenhuis Oost Limburg, a hospital in Genk, Belgium, said in a statement.
“Unfortunately, fetal heart rate is limited to hospital settings, and there is no tool to objectively and accurately monitor fetal movement. We are excited to be part of the research to quantify fetal movements and fetal heart rate in ambulatory settings. The clinical relevance, for instance, is in pregnancies with growth retarded fetuses (+/- 5 percent) where we do not have any decent day-by-day monitoring today, is unquestionable.”